Zobrazeno 1 - 10
of 65
pro vyhledávání: '"M, Arigita"'
Publikováno v:
Hipertensión y Riesgo Vascular. 37:147-151
Autor:
M. Arigita
Publikováno v:
Hipertensión y Riesgo Vascular. 36:59-62
Autor:
I. Soveral, M. Arigita, M. Porcar, S. Fernandez, H. Ayuso, B. Valenzuela‐Alcaraz, A. Borrell, M. Del Rïo
Publikováno v:
Ultrasound in Obstetrics & Gynecology. 60:135-135
Publikováno v:
Hipertension Y Riesgo Vascular
Autor:
M, Arigita
Publikováno v:
Hipertension y riesgo vascular. 36(2)
Autor:
Anna Soler, M. Arigita, Raquel Mula, Antoni Borrell, Virginia Borobio, Aurora Sánchez, Maribel Grande
Publikováno v:
Prenatal Diagnosis. 34:982-985
Objective The aim of this study was to assess the role of nuchal translucency (NT) in the prediction of unbalanced translocation in offspring of couples in which one of the parents is a balanced translocation carrier. Material and methods From Januar
Autor:
R. Garcia-Moreno, Anna Goncé, M. Arigita, Amelia Acera, E. Baldrich, A. Rodriguez-Veret, A. Seres, Anna Torrent, M. Muñoz-Cortes, Gemma Falguera, Dolors Guix, Virginia Borobio, Antoni Borrell, E. L. Lopez-Quesada
Publikováno v:
Ultrasound in Obstetrics & Gynecology. 39:396-400
Objective To assess a new contingent screening strategy for Down syndrome completed in the first trimester. Methods First-trimester screening combining nuchal translucency thickness measurement and assessment of serum analytes (combined test) was off
Publikováno v:
Ultrasound in Obstetrics & Gynecology. 39:157-163
Objectives To determine the sensitivity of first-trimester ultrasound for diagnosing different structural anomalies in chromosomally normal pregnancies, and to establish the role of aneuploidy markers in the detection of abnormalities. Methods This w
Publikováno v:
Prenatal Diagnosis. 31:1184-1188
Objectives To assess the prenatal ultrasound detection rates (DR) of neural tube defects (NTDs) and its evolution over the 1992 to 2006 period in the pregnant population of the city of Barcelona. Methods Data on the population-based register of birth
Publikováno v:
Prenatal Diagnosis. 31:1164-1168
Objective To assess the predictive value of fetal nuchal translucency (NT) measurement in the prenatal diagnosis of single-gene disorders. Methods From January 1996 to December 2006, fetal NT was prospectively measured before chorionic villi sampling